Overview of the finding A new study published in Science Translational Medicine by researchers at The University of Texas MD Anderson Cancer Center reports a previously unrecognized therapeutic vulnerability in an aggressive subtype of triple-negative breast cancer (TNBC). Led by a team including Dr. Khan, the study identifies a molecular weakness that could be exploited…